Granted, tenecteplase is approved by the FDA stateside but has yet to clear Japanese regulators. Study authors noted that the ...

Adding encorafenib (Braftovi) and cetuximab (Erbitux) to FOLFIRI chemotherapy significantly improved progression-free ...

In " Beyond Diagnosis: Multiple Myeloma," Cleveland Clinic hematologist Sandra Mazzoni, DO, and host John Mangels continue ...

Plasma exchange with albumin 5% (Albutein 5%, PE-A5%) added to standard medical treatment (SMT) improved outcomes in patients ...

In various nursing forums, nurses have candidly shared their experiences with mental health challenges. Many have also ...

The FDA warned that "Big Dick Energy!" -- a supplement touted for male sexual enhancement -- has the hidden ingredient ...

CHICAGO -- Patients who skipped maintenance therapy after a complete response to upfront treatment with a PD-1 inhibitor lived just as long as those who had 3 years of maintenance, data from a cohort ...

Over 26% of U.S. adults with a normal BMI met new criteria for clinical obesity proposed by the Lancet commission. About 78% of adults had excess adiposity if defined by using two or three abnormal ...

CHICAGO -- Adding a novel cereblon E3 ligase modulation (CELMoD) drug to a standard multiple myeloma regimen significantly improved progression-free survival (PFS) in a vulnerable population of ...

Tardive dyskinesia (TD), a movement disorder that causes involuntary movements often triggered by antipsychotic exposure, has appeared in the DSM for decades. Despite advancements in diagnostic tools ...

The FDA approved the oral antiviral agent ensitrelvir (Xocova) to help prevent COVID-19 in people ages 12 years or older who were exposed to the SARS-CoV-2 virus, drugmaker Shionogi announced.